WKN: | A0MKAC |
ISIN: | ES0134950F36 |
Land: | Spanien |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Faes Farma-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 15. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2019 | 2,51 | 4,41 | 75,70% |
2 | 2015 | 1,33 | 2,22 | 66,92% |
3 | 2013 | 1,14 | 1,89 | 65,79% |
4 | 2012 | 0,81 | 1,14 | 40,74% |
5 | 2009 | 1,53 | 2,09 | 36,60% |
6 | 2016 | 2,22 | 2,74 | 23,42% |
7 | 2025 | 3,43 | 4,23 | 23,32% |
8 | 2024 | 3,14 | 3,43 | 9,24% |
9 | 2022 | 3,24 | 3,41 | 5,25% |
10 | 2021 | 3,14 | 3,24 | 3,18% |
11 | 2018 | 2,48 | 2,51 | 1,21% |
12 | 2023 | 3,41 | 3,14 | -7,92% |
13 | 2017 | 2,74 | 2,48 | -9,49% |
14 | 2010 | 2,09 | 1,69 | -19,14% |
15 | 2020 | 4,41 | 3,14 | -28,80% |
16 | 2014 | 1,89 | 1,33 | -29,63% |
17 | 2011 | 1,69 | 0,81 | -52,07% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2011 | 1,69 | 0,81 | -52,07% |
2 | 2014 | 1,89 | 1,33 | -29,63% |
3 | 2020 | 4,41 | 3,14 | -28,80% |
4 | 2010 | 2,09 | 1,69 | -19,14% |
5 | 2017 | 2,74 | 2,48 | -9,49% |
6 | 2023 | 3,41 | 3,14 | -7,92% |
7 | 2018 | 2,48 | 2,51 | 1,21% |
8 | 2021 | 3,14 | 3,24 | 3,18% |
9 | 2022 | 3,24 | 3,41 | 5,25% |
10 | 2024 | 3,14 | 3,43 | 9,24% |
11 | 2025 | 3,43 | 4,23 | 23,32% |
12 | 2016 | 2,22 | 2,74 | 23,42% |
13 | 2009 | 1,53 | 2,09 | 36,60% |
14 | 2012 | 0,81 | 1,14 | 40,74% |
15 | 2013 | 1,14 | 1,89 | 65,79% |
16 | 2015 | 1,33 | 2,22 | 66,92% |
17 | 2019 | 2,51 | 4,41 | 75,70% |